<?xml version="1.0" encoding="UTF-8"?>
<p>The multicenter ANRS CO6 PRIMO cohort has enrolled in France more than 1900 participants with PHI since November 1996, which were diagnosed on the basis of a negative or incomplete Western blot (no anti-p68 or anti-p34) with detectable HIV-1 RNA for 96% of cases or on the basis of an interval of &lt;3–6 months between a negative and a positive enzyme-linked immunosorbent assay (ELISA) for the remaining cases [
 <xref ref-type="bibr" rid="CR25">25</xref>]. All were treatment naïve at enrollment. Demographic, behavioral, biological (CD4, HIV-RNA) and clinical data of the participants were collected and organized anonymously in a common electronic archive.
</p>
